STACIE LITTERAL: Open Payments
NPI 1235852005 · ASHLAND, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,590 in 88 payments from 11 companies in 2025. Trend: 2023 $1,490 · 2024 $1,481 · 2025 $1,590
Food & beverage: $1,590
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $518 |
| Ardelyx, Inc. | 19 | $278 |
| Janssen Biotech, Inc. | 10 | $182 |
| Novo Nordisk Inc | 8 | $180 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $139 |
| Regeneron Healthcare Solutions, Inc. | 5 | $121 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $56 |
| GENZYME CORPORATION | 2 | $49 |
| Madrigal Pharmaceuticals | 2 | $35 |
| Smith+Nephew, Inc. | 1 | $17 |
Products named: IBSRELA, RINVOQ, TREMFYA, CREON, DUPIXENT, Wegovy, ENTYVIO, XIFAXAN.
Industry payments across KY — which companies pay providers there.
